Will you have Hairloss with Sotret - from FDA reports


Hairloss is found among people who take Sotret, especially for people who are female, 20-29 old , have been taking the drug for 1 - 6 months, also take medication Accutane, and have Acne cystic. This study is created by eHealthMe based on reports of 2,530 people who have side effects when taking Sotret from FDA, and is updated regularly.

What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on isotretinoin (the active ingredients of Sotret) and Sotret (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Hairloss are also considered in the study.

What is Sotret?

Sotret has active ingredients of isotretinoin. It is often used in acne. (latest outcomes from Sotret 2,578 users)

What is Hairloss?

Hairloss has been reported by people with multiple sclerosis, rheumatoid arthritis, breast cancer, breast cancer female, high blood pressure (latest reports from 136,892 Hairloss patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.

On Mar, 14, 2019

2,530 people reported to have side effects when taking Sotret.
Among them, 50 people (1.98%) have Hairloss

Number of reports submitted per year:

Could Sotret cause Hairloss?

Time on Sotret when people have Hairloss *:

  • < 1 month: 3.85 %
  • 1 - 6 months: 84.62 %
  • 6 - 12 months: 11.54 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hairloss when taking Sotret *:

  • female: 53.66 %
  • male: 46.34 %

Age of people who have Hairloss when taking Sotret *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 18.75 %
  • 20-29: 56.25 %
  • 30-39: 9.38 %
  • 40-49: 12.5 %
  • 50-59: 3.12 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  1. Heavy Or Prolong Menstrual Bleeding: 1 person, 2.00%
  2. Dermatitis Exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss): 1 person, 2.00%
  3. Cutaneous Lupus Erythematosus (own immune system attacks various cells causing a wide variety of signs and symptoms): 1 person, 2.00%
  4. Acne Cystic (skin problems that cause pimples): 1 person, 2.00%

Top co-used drugs for these people *:

  1. Accutane: 13 people, 26.00%
  2. Amnesteem: 11 people, 22.00%
  3. Minocin: 8 people, 16.00%
  4. Aldactone: 8 people, 16.00%
  5. Retin-A: 8 people, 16.00%
  6. E-Mycin: 8 people, 16.00%
  7. Cleocin T: 5 people, 10.00%
  8. Zenatane: 2 people, 4.00%
  9. Lymecycline: 1 person, 2.00%
  10. Vitamin E: 1 person, 2.00%

Top other side effects for these people *:

  1. Depression: 17 people, 34.00%
  2. Dry Skin: 16 people, 32.00%
  3. Inflammatory Bowel Disease: 14 people, 28.00%
  4. Rashes (redness): 11 people, 22.00%
  5. Oral Herpes (viral infection of mouth): 10 people, 20.00%
  6. Cheilitis (infection of lips): 9 people, 18.00%
  7. Xerosis (abnormal dryness of the skin or mucus membranes): 8 people, 16.00%
  8. Intestinal Obstruction: 8 people, 16.00%
  9. Neck Injury: 8 people, 16.00%
  10. Sunburn: 8 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you have Hairloss while taking Sotret?

You are not alone:

Related publications that referenced our studies

Related studies

Drugs that are associated with Hairloss
Hairloss (3,131 drugs)
Could your condition cause Hairloss
Hairloss (2,888 conditions)
Sotret side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sotret
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Sotret with similar drugs

What would happen?

Predict new side effects and undetected conditions when you take Sotret and have Hairloss

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.